# Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

> **NCT06782646** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **The University of Hong Kong** · enrollment: 100 (estimated)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Berberine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06782646
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-01
- **Primary completion:** 2025-12
- **Final completion:** 2026-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782646, "Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06782646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*